drugset / Trial / NCT02196636
A Phase 1 Study of RO6806127 in Healthy Male Volunteers
RandomizedParallel-groupDouble-blind
Summary
This two-part study will assess the safety and tolerability of single ascending oral doses of RO6806127 in a group of healthy male participants and investigate the effect of high fat and high caloric food on the relative bioavailability of a single oral dose of RO6806127 in a separate group of healthy male participants. The relationship between drug exposure and tolerability will be explored.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RG7342 | Unknown | — | Oral |
Indications
No indication recorded.